Pharmaceutical intermediates, as some chemical raw materials or chemical products in the synthesis process of pharmaceutical production, have always been essential products in the pharmaceutical industry. Choosing reliable and trustworthy manufacturers is the guarantee for pharmaceutical manufacturers to produce drugs. Zouping Mingxing Chemical Co., Ltd. was established in 2002 (the sales company is Zouping Mingyuan Import and Export Trade Co., Ltd.). It is a professional manufacturer of pharmaceuticals, pesticide intermediates, food additives, electronic flame retardants, and fine chemical raw materials.
Industry status analysis
After the glorious pharmaceutical intermediate industry in the late 1990s, the competition among enterprises has basically entered a mature stage. The competition among enterprises has reached fierce heat, and each other is fighting for the remaining strength. Whoever can persist will be the survivor. At the same time, seduced by various legends and other factors, new investors continue to enter the industry with the dream of “gold rushing”. However, as the country requires pharmaceutical companies to carry out GMP certification and various overseas certifications, the investment scale of the pharmaceutical industry is showing It has risen exponentially, and how to generate economic and social benefits with limited funds and energy has become the goal pursued by every pharmaceutical intermediate investor.
The trajectory goes from medicine to medicine
The impact of the economic globalization process has a more profound impact on my country’s economy than the idea that every production enterprise does not need to be large but should concentrate its capital and energy on the industries and fields that it is good at. Other supporting materials and conditions can be completed by social collaboration. Through the formation of a product chain, the two parties can achieve a win-win situation. Under the influence of this concept, the pharmaceutical industry transfers the processing of some primary products such as solvent recovery to cooperative companies for completion. .

As the cooperation between the two parties continues to deepen, pharmaceutical companies have gradually transferred some products with higher added value and more technically difficult products to chemical plants to produce products such as p-hydroxybenzaldehyde used in the production of cephalosporin antibiotics. This makes this branch of the industry in In the 1990s, it has achieved rapid development and created a batch of pharmaceutical intermediate enterprises with an output value of tens of millions to billions. At present, the industry has developed to a stage of closer cooperation with pharmaceutical companies. The manufacturers of pharmaceutical intermediates directly synthesize APIs, and sell the products in the form of chemical products to pharmaceutical companies for refining, and then sell pharmaceutical intermediates as drugs. The industry can further extend the product chain, increase product profits and improve sales stability. Pharmaceutical companies reduce investment and focus their limited funds and energy on aseptic packaging, which they are good at. Because of the pharmaceutical intermediate industry, there is no medicine. It is impossible for the production license of the product to compete with pharmaceutical companies for the market, so the cooperation between the two parties is complementary to a certain extent.
Basic conditions are still restricting development
In recent years, the rapid development of the pharmaceutical intermediate industry has aroused the coveting of many investors. Companies producing pharmaceutical intermediate raw materials have sprung up all over the country. At the same time, they were eliminated at a similar speed. Many technicians engaged in the development of pharmaceutical intermediate products have also intervened in the industry in various forms. However, with the closure of corresponding companies, the development of this industry seems to be ebb and flow. Luo has taken away the back of many losers in a hurry. The author is one of many losers.
With capital and technology, products can be produced. However, reproduction can only be carried out if the product is sold and the funds are recovered in time. Because the pharmaceutical intermediate industry and the pharmaceutical industry have a close relationship, product sales are also very delicate. The competition between suppliers has been transformed into comprehensive strength among enterprises. The specific content of the competition includes: intuitive factory appearance, production workshop and laboratory equipment, product packaging and quality, intangible including technical force, after-sales service, corporate culture, business philosophy, etc. Therefore, a comprehensive market background is also one of the indispensable conditions.

Zouping Mingxing Chemical Co., Ltd. is a trusted developer of pharmaceutical intermediates, specialty APIs, and plant extracts. Set up a research and development center, a GMP pilot workshop, integrate production, education and research with universities to accelerate the commercialization of production and research. And the company’s own strict management and control system for R&D, production, and quality in accordance with strict regulatory regulations. Become a large-scale export company integrating industry and trade. Relying on a strong R&D team, rich production experience and a quality assurance system built around “ISO9001-2000″, we have established good cooperative relations with many customers in 48 countries and regions including the United States, Japan, and South America.

Post time: Sep-24-2021